Oncology Flashcards

1
Q

What is the defining characteristic of a malignant tumour?

A

It’s ability to invade and metastasise to other tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Give a definition of cancer cells

A

Cells which undergo uncontrolled and unregulated cell proliferation with the ability to metastasise to other places in the body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Name 4 of the 10 hallmark characteristics of cancer cells according to Hanahan and Weinberg.

A
Sustaining proliferative signalling
Evading growth suppressors
Avoiding immune destruction
Enabling replicative immortality
Tumour-promoting inflammation
Activating invasion and metastasis
Inducing angiogenesis
Genome instability and mutation
Resisting cell death
Deregulating cellular energetics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Name the 5 stages of the cell cycle and what happens at each

A
G0= resting phase
G1= pre-DNA synthesis
S1= DNA synthesis
G2= post-DNA synthesis
M= Mitosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the 3 different sub-populations of cells present in a tissue at one time?

A

1) Cells in resting phase that can be recruited into cell cycle
2) Cells that are terminally differentiated and can’t be recruited
3) Cells that are actively proliferating

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the tumour marker in ovarian cancer?

A

Ca-125

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the UK National Screening Committee definition of screening?

A

A process of identifying apparently healthy people who may be at increased risk of a disease or condition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

List 4 of Wilson’s criteria for screening.

A

1- Important health problem
2- Accepted treatment
3- Facilities for diagnosis and treatment
4- Recognisable latent or early symptomatic stage
5- Suitable test or examination
6- Test acceptable to the population
7- Natural history of condition adequately understood
8- Agreed policy on whom to treat
9- Cost-effectiveness
10- Case-finding should be a continuous process

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the grade of a tumour?

A

The extent to which the neoplasm resembles its cells or tissue of origin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Which type of tumours more resemble their parent tissue: well differentiated or poorly differentiated?

A

Well differentiated
Poorly differentiated tumours do not resemble their parent tissue, tend to grow more rapidly and behave more aggressively compared to well differentiated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What does the stage of a cancer describe?

A

Its size and how far it has spread

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the components of the TNM staging classification?

A

Tumour, Nodes, Metastasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Metastasis to distant organs generally correlates with what stage of cancer?

A

Stage 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Symptoms with a risk of cancer warrant what type of referral?
What does this mean?

A

Suspected Cancer Pathway Referral. Means a patient will have the appropriate investigations and specialist review within 2 weeks

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is it imperative to identify before deciding on cancer treatment?

A

The aims of the treatment e.g. curative or palliative.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the primary treatment for most early/non-metastatic solid tumours?

A

Surgical resection of primary areas and areas at risk of microscopic spread (e.g. sentinel LNs in breast cancer)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What might cause recurrence of disease following resection of a primary tumour?

A

The presence of microscopic disease/micrometastases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What is the difference between neo-adjuvant and adjuvant chemotherapy?

A
Neo-adjuvant= prior to surgery/radiotherapy
Adjuvant= post-surgery
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Briefly outline the mechanism of action of radiotherapy.

A
  • Makes free radicals and ROS are formed
  • They react with covalent bonds in DNA
  • Causes apoptosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are the three main ways of delivery radiotherapy?

A

External beam therapy, brachytherapy (internal to the body) and systemically

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What produces the external beam radiation therapy?

A

A linear accelerator (LINAC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What does the radiation dose entail and what is it measured in?

A

The amount of irradiation absorbed by each kilogram of tissue, measured in Grays (Gy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

When treating a patient with curative intent with radiation, what treatment regime (total dose, dose pe fraction) would be used and why?

A

High total dose but spread over many fractions to reduce the risk of long term adverse effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

When treating a patient with palliative intent with radiation, what treatment regime (total dose, dose per fraction) would be used and why?

A

High dose per fraction but low overall dose to reduce short-term adverse effects.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Some chemotherapy drugs are radio-sensitising, what does this mean?

A

The chemotherapy makes the cancer cells more sensitive to radiotherapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is the most common acute side effect of radiotherapy. Is this dependent or independent of the area of the body being treated?

A

Fatigue. Independent.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

List 4 other possible side effects of radiation.

A

Nausea, vomiting, anorexia, mucositis, oesophagitis, diarrhoea

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Side effects are typically worst how long following completion of treatment?
After how long have they typically resolved?

A

2 weeks.

6 weeks.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

True or false: early side effects of radiation generally involve local inflammation and late side effects involve local fibrosis.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Give 2 examples of types of molecular targeted therapies used for cancer treatment.

A

Small molecule inhibitors e.g. Tyrosine kinase inhibitors
Monoclonal antibodies
Immunotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

What part of the cell cycle do these anti-cancer drugs affect:
1- corticosteroids
2- vinca alkaloids
3- antimetabolites

A

1- G1
2- Mitosis
3- S1

32
Q

What are the 4 broad categories of cytotoxic chemotherapies?

A

Alkylating agents, antimetabolites, DNA linking agents, and ‘natural products’ (cytotoxic antibiotics, taxanes)

33
Q

How do alkylating agents work?

A

They add an alkyl group to the guanine base of DNA, so crosslinks form between these. This disrupts DNA synthesis by preventing DNA replication and RNA transcription.

34
Q

True or false, alkylating agents only work in phase G1 of the cell cycle?

A

False, they work at all stages of the cell cycle, they aren’t phase specific.

35
Q

Antimetabolites are cell specific. What phase do they particularly effect, and what phase do they have very little effect?

A

Primarily effect the synthetic/S phase. Very little effect on G0

36
Q

Are antimetabolites most effective against slow or rapidly growing cancers?

A

Rapidly growing

37
Q

Generally how do antimetabolites work?

A

Inhibition of enzymes or metabolites involved in DNA or RNA synthesis.

38
Q

How do DNA linking agents work?

A

They contain platinum complexes which produce inter-strand and intra-strand DNA cross links which prevents replication.

39
Q

Are DNA linking agents cell cycle specific or non-specific?

A

Non-specific

40
Q

What is a big reason why many chemotherapy treatment regimens fail?

A

Drug resistance- either natural or developed

41
Q

Give 5 side effects of chemotherapy

A

Nausea, alopecia, heart failure, immune suppression, renal impairment, hepatic impairment, skin rashes, bowel upset, peripheral neuropathy, taste changes

42
Q

What are the three main groups of drugs which make up the molecular targeted therapies?

A

Monoclonal antibodies, small molecule kinase inhibitors, and immunotherapy

43
Q

What two routes are monoclonal antibodies administered?

A

IV or S/C

44
Q

What part of the cell do monoclonal antibodies work on?

A

Recognise specific protein markers on the outside of cells

45
Q

Small molecule inhibitors act intracellularly, typically on what type of pathways?

A

Tyrosine kinase

46
Q

What do small molecule inhibitors names end in? How are they administered?

A

-nib. Usually given orally

47
Q

How does immunotherapy work?

A

Makes cancer cells that have previously managed to hide from the body’s immune system visible again, stimulating the body’s own immune response to kill off the abnormal cancer cells

48
Q

When should patients be treated for neutropenic sepsis?

A

When they have a temperature of >= 38 and an absolute neutrophil count <=1 x 10^9/L

49
Q

You should suspect neutropenic sepsis in any patients presenting with a new clinical deterioration within how many weeks of cytotoxic chemotherapy.

A

Within 6 weeks.

50
Q

Name two associated risk factors with neutropenic sepsis

A

Poor nutrition, mucosal barrier defect, central venous line, abnormal host colonisation

51
Q

What investigations would you perform in suspected neutropenic sepsis?

A

FBC, U&E, LFT, CRP/ESR, coag screen, septic screen (blood cultures, urine output, lactate), clinically relevant swabs/cultures, CXR

52
Q

What is the initial management of neutropenic sepsis?

A

Initial empirical antibiotics (Tazocin) within an hour of arriving at hospital. Do not wait for results from blood tests.

53
Q

After how long, if patient is improving, would you swap to oral antibiotics from IV in neutropenic sepsis? What to do if not improving?

A

24-48 hours.

Start second line antibiotics, then if that doesn’t work consider opportunistic infections

54
Q

Give an example of opportunistic infections that may infect patients on chemotherapy.

A

PCP, fungal infections

55
Q

Patients with high risk of developing significant neutropenia should be offered prophylaxis with what three possible agents?

A

Fluoroquinolone antibiotics, anti-fungals, Granulocyte colony-stimulating factor

56
Q

Approximately 40% of circulating calcium is bound to what?

A

Albumin

57
Q

Why should corrected calcium be used for diagnosing hypercalcaemia?

A

Because it’s only unbound, ionised calcium that is physiologically important

58
Q

Give 2 causes of hypercalcaemia

A

Osteolysis (lytic bone mets), humoral (PTHrP in SCLC), dehydration, other tumour specific mechanisms

59
Q

What is the presentation of hypercalcaemia?

A

Bones, stones, groans, and psychic moans

60
Q

Give further investigations for hypercalcaemia.

A

Repeat sample, PTH, ECG, imaging for bone mets

61
Q

What ECG change may be caused by hypercalcaemia?

A

Shortened QT interval

62
Q

What are the two main steps in the management of hypercalcaemia?

A
1= correct dehydration. (0.9% NaCl 4-6L)
2= IV bisphosphonates (zolendronate or pamidronate commonly used)
63
Q

Give 2 side effects of bisphosphonates

A

Flu-like symptoms, bone pain, myalgia, reduced phosphate levels, nausea and vomiting, headache, osteonecrosis of the jaw

64
Q

What drug is used in persistent or relapsed hypercalcaemia of malignancy and how does it work?

A

Denosumab: monoclonal antibody that inhibits RANK ligand, so inhibiting the maturation of osteoclasts

65
Q

What are the two mechanisms of malignant spinal cord compression?

A

Crush fracture, or soft tissue tumour extension

66
Q

Give 3 possible presenting features of spinal cord compression.

A

Worsening back pain, weakness in limbs below compression, sensory level, bowel or bladder dysfunction (LATE SIGN), radicular pain, UMN signs below that lesion

67
Q

What is the gold standard investigation for malignant spinal cord compression?

A

MRI whole spine

68
Q

What are the 4 components of management of malignant spinal cord compression?

A
1= high dose corticosteroids
2= definitive treatment depending on tumour and patient (surgery, radiotherapy, chemotherapy, hormone deprivation)
3= Analgesia
4= VTE prophylaxis and pressure sore prevention
69
Q

Recovery from spinal cord compression is uncommon if what two features are present?

A

Paraplegia and sphincter involvement

70
Q

What structure provides the venous drainage of the head, neck, upper limb and upper thorax?

A

Superior vena cava

71
Q

Give 4 causes of superior vena cava obstruction

A

Thrombus, intravascular device, direct tumour invasion, tumour pressing onto the vessel, lung cancer, lymphoma, germ cell tumours, fibrosing mediastinitis

72
Q

Give 3 symptoms of SVC obstruction

A

Chest pain, dyspnoea, cough, neck and face swelling, arm swelling, dizziness, headache, visual disturbance, syncope

73
Q

Give 2 signs of SVC obstruction.

A

Dilated veins (arms, neck, anterior chest), oedema (of upper torso, arms, neck and face), severe respiratory distress, cyanosis, engorged conjunctiva, convulsions and coma

74
Q

SVC obstruction may be a clinical diagnosis but what are two possible investigations you may do?

A

CXR, CT scan

75
Q

What two actions may provide symptomatic relief of SVC obstruction?

A

Elevation of head and oxygen therapy

76
Q

What is the management of SVC obstruction?

A

High dose steroids (acutely), endovascular stenting. May consider chemotherapy, radiotherapy, anticoagulation (if central vein thrombosis present)